B1CTcu5: A frog-derived brevinin-1 peptide with anti-tuberculosis activity.


Journal

Peptides
ISSN: 1873-5169
Titre abrégé: Peptides
Pays: United States
ID NLM: 8008690

Informations de publication

Date de publication:
10 2020
Historique:
received: 04 04 2020
revised: 12 07 2020
accepted: 13 07 2020
pubmed: 18 7 2020
medline: 20 7 2021
entrez: 18 7 2020
Statut: ppublish

Résumé

Tuberculosis (TB) is a devastating infectious disease that causes a high rate of mortality. Drugs with new modes of action are needed to overcome this scenario. Cationic antibacterial peptides can serve as a potential alternative to existing TB drugs as they target the entire bacterial membrane for activity, thereby reducing the probability of development of drug resistance. In this study, we report anti-tuberculosis activity of B1CTcu5, a peptide that belongs to brevinin-1 family of antimicrobial peptides. This peptide possesses potent in vitro inhibitory activity against M. tuberculosis at 12.5 μg/mL but was not active against M. smegmatis. B1CTcu5 successfully eliminated intracellular mycobacteria without inducing cytotoxicity to the human macrophages at the concentrations tested. This peptide can be used as a template to design peptide-based anti-tubercular agents.

Identifiants

pubmed: 32679168
pii: S0196-9781(20)30122-4
doi: 10.1016/j.peptides.2020.170373
pii:
doi:

Substances chimiques

Amphibian Proteins 0
Antimicrobial Cationic Peptides 0
Antitubercular Agents 0
brevinin-1 protein, Rana 145963-49-1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

170373

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Parvin Abraham (P)

Chemical Biology Laboratory, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, 695014, India. Electronic address: parvinabraham@gmail.com.

Leny Jose (L)

Mycobacterium Research Group, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, 695014, India.

Tessy Thomas Maliekal (TT)

Cancer Research Division, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, 695014, India.

R Ajay Kumar (RA)

Mycobacterium Research Group, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, 695014, India.

K Santhosh Kumar (KS)

Chemical Biology Laboratory, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, 695014, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH